Ruti Aga's Six Years: Two Written by a Syringe, Four by a Prescription Pad

The Athletics Integrity Unit released its statement on a Thursday, and one sentence in it I read three times, because on the first pass I assumed I had misread the number. Six years. Ruti Aga, 32, Ethiopia, women's marathon. She won a half marathon in China in March. A sample was collected after that race. She had been provisionally suspended since 10 September, and now the ban runs six years from the same date.

The six years splits in two. Two years for the molecule that appeared in the sample. Four years for the paper that was produced after it. One-third of the sanction came from her body and two-thirds from stationery.

The clinic named on the prescription does not exist. The person who wrote it holds no medical registration — he is a family member. The pad it was written on was disowned by the clinic in plain terms. Three separate verifications, three failures.

I have been reading athletics paperwork for eighteen years — entry lists, sanction letters, budget annexes, and the statements that name an athlete but never a doctor. This case gave me everything that frightens me about that habit, plus the thing that usually gets skipped: a substance the headlines mislabelled, and a penalty whose largest component came not from the mistake but from the attempt to hide it.

What the statement does not say

Before I read the ruling, I counted the gaps. No time from the March half marathon. No splits. No field strength. No weather. Not even the name of the race. No word on whether the result and prize money were annulled. No year for the ban's expiry. And not a single sentence from the Ethiopian federation — the statement contains only the AIU.

For an athlete who won the 2026 Tokyo Marathon and holds three World Marathon Majors runner-up finishes, a six-year sanction notice that omits her personal best is not carelessness. The AIU writes disciplinary notices, not profiles. The consequence for the reader is that any assessment has to be welded to external race records, and external race records drift. The public record lists 2:18:34 in Berlin 2026 for second place and 2:20:40 in Tokyo 2026 for the win. I mark those figures separately because they come from results sheets, not from the statement.

Who Aga is, and what the March race actually was

A 32-year-old 2:18–2:20 marathoner in Ethiopia is the equivalent of a domestic cricketer scoring 700 runs a season and never getting a national call-up. Aga has no global championship medal — no World Championships, no Olympics. What she has is one Major title, three Major second places, and sustained presence in a tier where the money arrives as an appearance fee rather than a medal.

That is why the Chinese race matters economically, not athletically. The Asian label-race circuit is a specific market for East African marathoners between Majors: large appearance fees, few races, low risk, and — this is the newer part — the heaviest testing density. The races with the biggest budgets carry the most AIU samples. That is not a coincidence. It is the point where the appearance-fee economy and the testing economy stand on the same start line.

Road racing also has a tight in-competition definition: from 23:59 the day before the race until the race ends. An injection given four days earlier is still a violation if residue is present in the race-day sample. That technicality is the foundation stone of this entire case, and the headlines skipped it.

The arithmetic of six years

Two years for presence. Four years for tampering — producing a false document during the investigation. Six total.

The arithmetic is itself the story. Under the World Athletics rules, where the substance is a Specified Substance and the athlete can establish no fault or no significant fault, the presence sanction can be reduced, sometimes to a reprimand. Two years means the panel declined that mitigation, but it did not go above the baseline either, which means aggravating intent on the presence charge was not proven.

And the four? That is the Code's standard tampering sanction. No leniency there, because the evidence was documentary and the document was proven false.

One thing is tangled inside this arithmetic: forged documentation is itself circumstantial evidence of concealment intent, yet the panel did not use it to escalate the presence sanction. It charged it separately. Technically clean, practically brutal, because the outcome is identical — six years.

The substance is not a steroid

Here I have to make the correction that matters, and it is not semantics.

Reports calling this a prohibited steroid are technically wrong. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List, not an anabolic steroid, class S1. It is an anti-inflammatory — the drug injected into a swollen knee. Distance runners' knees receive it routinely, and there is no moral crisis attached to it.

S9 has a specific status. These substances are prohibited in-competition only, not out of competition. And from 1 January 2026 WADA added all injectable routes to the prohibition; previously only oral, intravenous and rectal routes were listed. A therapeutic knee injection today is entirely legal out of competition. It becomes a violation the moment residue is present in an in-competition sample.

Which means the hinge of this case was never "steroid use." The hinge was: which route, and how many days before the competition. The distance between a legitimate treatment and a violation here is measured in hours and days, not in ethics.

And that is where the case becomes interesting. Had Aga possessed genuine medical records — injection date, dose, route, and the washout calculation that followed — a real defence existed. Reaching it required a credentialed team physician to sign a document that lived inside a hospital file. Instead, a prescription was manufactured for a clinic that does not exist.

Three verifications, three failures

First, the clinic's existence. The institution named on the prescription was not found. This is the cheapest and first step in any investigation: one phone call, one registry search. Whoever made this document did not consider that someone might pick up a phone.

Second, the prescriber's credentials. A family member with no medical registration. The name and title on the document match no one in any register.

Third, the pad's authenticity. The defence offered that the prescription had been written on an old pad from a former workplace. The clinic disowned the pad outright.

Three verifications, three failures. This is not three pieces of bad luck. It is the output of a process in which, at no single checkpoint, was there a qualified person able to say the document is wrong — because there was no qualified person in the room.

The testing window, and an excuse that was mechanically sound

The knee-injury explanation is entirely plausible on the mechanics. Chronic knee synovitis is a known failure mode in marathoners; the joint absorbing 180–200 kilometres a week is the knee. Intra-articular methylprednisolone is standard sports medicine for it.

That plausibility is precisely what made it fatal. If the treatment was real, real records could have proven it. When someone manufactures a prescription instead of producing a file, they destroy the strongest link in their own defence. The substance cost two years; genuine paperwork might have cost far less.

And the testing window? An injection given days before a race can still be present on race day. It is a technical trap that catches athletes who have nobody to tell them when to stop.

The empty TUE box

One absence explains the whole case, and the statement never mentions it: a Therapeutic Use Exemption.

A properly managed athlete needing a glucocorticoid injection close to competition has two routes. Apply for a TUE and secure it. Or plan the route and timing so that no residue survives into the competition period. Neither happened here. A third route was chosen — the cheapest and the most dangerous.

The missing TUE is not a personal lapse; it is a structural signal. An athlete without a credentialed team physician eventually depends on whoever is closest — and the closest person is always family, not medicine.

The fourth year came from an interview

The four-year tampering sanction did not come from a document alone. It came from statements made during questioning. Part of this investigation was linguistic.

Translation and terminology in AIU interviews with East African athletes is a recurring and legitimate complaint. It is also true that when an athlete, asked a direct question, offers a story featuring a clinic that does not exist, that is not a translation error. That is a rehearsed account.

Which is why the two penalties here are of different species. Two years came from scientific evidence: a laboratory, a report, a number. Four years came from human evidence: a room, a microphone, and an answer somebody checked.

What gets annulled and what does not

The statement does not specify the disqualification scope. Standard AIU practice is unambiguous: the competition at which the sample was collected is disqualified, along with its prize money and any ranking points accrued after that date. The March half marathon win — recorded in news copy as a win — is now zero on paper.

The 2026 Tokyo title does not fall automatically. The violation is anchored to a later March race; absent a finding of earlier use, prior results stand. Her career will remain split in two: the part she won, and the part she was banned for. That is the final record, and it is an uncomfortable one.

Thirty-two to thirty-eight

At 32 a marathoner sits on the upper surface of the curve — decline beginning, experience fully banked. Six years later she is 38.

Against Ethiopian women's marathon depth, that number is not a penalty; it is a closed door. In a country with multiple sub-2:16 performers, there is no selection case for a 38-year-old whose name sits on a doping register. Functionally this is not a six-year ban. It is career death — and it came from the paper, not the molecule.

The convenience of the word "steroid"

Filing this under steroids is not an innocent error. It places the case on the shelf where anabolic cases sit — stories of mass, power and deceit — when the story here is a swollen knee and a prescription pad.

Two consequences follow. It makes sanction comparison impossible, because you cannot compare this to an EPO case when EPO has a demonstrated endurance effect and glucocorticoids do not. And it hides the real problem: the athlete had no credentialed physician. Four of the six years were imposed for something with no performance benefit attached. The largest component of this penalty is for paperwork, not for the body.

Six bans, six silences — and one pattern I could not unsee

In 2026 I spent nine days at the National Institute of Sports in Patiala. Six Indian women athletes were banned between June and December that year, several of them members of the 2026 Commonwealth and Asian Games 4x400 squads. I went with the boring question nobody asked: who signed off on their supplements?

Usually nobody. Four of the six held sports-quota posts with Railways or a state police force, where the "team doctor" was a visiting physician on a monthly roster, not a staff member.

Ruti Aga's case is the same architecture written in another language. No team doctor, so a family member became one. Nobody to sign, so a document was manufactured. The ledger doesn't lie: where the file has no doctor's name, the documents will be forged.

A forged prescription is evidence of inequality

The four-year tampering sanction hits rich and poor athletes differently. A wealthy federation has a medical desk, a TUE desk, and a lawyer explaining from day one what to do and what not to. A thin entourage has a phone and a relative who arranges things.

When the first group errs, it says the date was entered incorrectly and gets a correction window. When the second errs, it forges. The tampering charge, in practice, becomes a surrogate for unequal resourcing.

None of which makes forgery acceptable. It means that when we applaud six years as toughness, we decline to look at the structure that made the forgery the available option. The real question is not how long the ban is. It is what choice she had six years earlier, and what that choice cost.

**What